SARS-CoV-2 3CL-protease inhibitors derived from ML300: investigation of P1 and replacements of the 1,2,3-benzotriazole.

Autor: Hooper A; Cleveland Clinic Lerner Research Institute., Macdonald JD; Cleveland Clinic Lerner Research Institute., Reilly B; Cleveland Clinic Lerner Research Institute., Maw J; Cleveland Clinic Lerner Research Institute., Wirrick AP; Cleveland Clinic Lerner Research Institute., Han SH; Cleveland Clinic Lerner Research Institute., Lindsey AA; Cleveland Clinic Lerner Research Institute., Rico EG; Cleveland Clinic Lerner Research Institute., Romigh T; Cleveland Clinic Lerner Research Institute., Goins CM; Cleveland Clinic Lerner Research Institute., Wang NS; Cleveland Clinic Lerner Research Institute., Stauffer S; Cleveland Clinic Lerner Research Institute.

Publikováno v: Research square [Res Sq] 2023 May 11. Date of Electronic Publication: 2023 May 11.